Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Aratana Therapeutics, Inc. (NASDAQ: PETX).

Full DD Report for PETX

You must become a subscriber to view this report.


Recent News from (NASDAQ: PETX)

Breakfast Technical Briefing on BioLine Rx and Three More Biotech Stocks
Stock Research Monitor: PETX, BCRX, and BDSI LONDON, UK / ACCESSWIRE / May 17, 2018/ If you want a free Stock Review on BLRX sign up now at www.wallstequities.com/registration . In today's pre-market research, WallStEquities.com evaluates Aratana Therapeutics Inc. (NASDAQ: PETX ), Bi...
Source: ACCESSWIRE IA
Date: May, 17 2018 09:00
Engaged Capital updates on portfolio holdings
Activist investor Engaged Capital updates on its holdings at the end of Q1. More news on: Finisar Corporation, Aratana Therapeutics, Apogee Enterprises, Inc., Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: May, 15 2018 14:21
Aratana's (PETX) CEO Steven St. Peter on Q1 2018 Results - Earnings Call Transcript
Aratana Therapeutics (PETX) Q1 2018 Results Earnings Conference Call May 4, 2018, 08:30 AM ET Executives Rachel Reiff - Corporate Communications Steven St. Peter - President and CEO Craig Tooman - Chief Financial Officer Analysts John Krieger - William Blair Bruce Jackson...
Source: SeekingAlpha
Date: May, 04 2018 15:15
Aratana Therapeutics beats by $0.01, misses on revenue
Aratana Therapeutics (NASDAQ: PETX ): Q1 EPS of -$0.19 beats by $0.01 . More news on: Aratana Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 03 2018 16:53
Aratana Therapeutics Reports First Quarter 2018 Financial Results
LEAWOOD, Kan. , May 3, 2018 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, announced its first quarter 2018 financial results. In the first...
Source: PR Newswire
Date: May, 03 2018 16:05
Recent Analysis Shows Waterstone Financial, Blue Bird, Proto Labs, American Assets Trust, MoSys, and Aratana Therapeutics Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Waterstone Financial, Inc. (NASDAQ:WSBF), Blue Bird Corporation (NASDAQ:BL...
Source: GlobeNewswire
Date: May, 02 2018 08:00
Aratana Therapeutics to Report First Quarter 2018 Financial Results
LEAWOOD, Kan. , April 12, 2018 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Friday, May 4, 2018 at 8:30...
Source: PR Newswire
Date: April, 12 2018 08:30
Aratana Therapeutics Confirms Receipt of Board Nominations
LEAWOOD, Kan. , April 5, 2018 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, confirmed that it has received a notice of nomination of three dire...
Source: PR Newswire
Date: April, 05 2018 09:29
After Hours Gainers / Losers (04/04/2018)
Top gainers: FB +3.4% . INF +1.6% . TWTR   +0.9% . More news on: Facebook, Brookfield Global Listed Infrastructure Income Fund, Twitter, Inc., Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: April, 04 2018 17:35
Midday Gainers / Losers (03/27/2018)
Gainers:  ASTC +32% . SHOS +31% . NSPR +28% . INNT +15% . TOPS +13% . MBII +13% . PETX +12% . HMNY +12% . ATNX +11% . MYOV +10% . More news on: Astrotech Corporation, Sears Hometown and Outlet Stores, Inc., InspireMD, Inc., , Read more ...
Source: SeekingAlpha
Date: March, 27 2018 12:59

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-175.515.575.605.4853207,025
2018-01-115.255.295.37865.25462,029
2018-01-105.065.255.285.0568330,206
2018-01-095.055.115.114.942,425,694
2018-01-085.205.025.204.81772,822

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-1838,480122,25931.4742Cover
2018-05-1716,58284,21619.6898Cover
2018-05-1614,92590,11216.5627Cover
2018-05-1516,74174,17522.5696Cover
2018-05-1423,09077,13429.9349Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PETX.


About Aratana Therapeutics, Inc. (NASDAQ: PETX)

Logo for Aratana Therapeutics, Inc. (NASDAQ: PETX)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: PETX)

      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 04 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 03 2018
      Amendment to a previously filed Form 4
      Filing Type: 4/AFiling Source: edgar
      Filing Date: May, 01 2018
      Amendment to a previously filed 10-K
      Filing Type: 10-K/AFiling Source: edgar
      Filing Date: April, 27 2018
      Filing by person(s) reporting owned shares of common stock in a public company >5%
      Filing Type: SC 13DFiling Source: edgar
      Filing Date: April, 05 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 05 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: March, 14 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: March, 14 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 13 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 13 2018

       

       


      Daily Technical Chart for (NASDAQ: PETX)

      Daily Technical Chart for (NASDAQ: PETX)


      Stay tuned for daily updates and more on (NASDAQ: PETX)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: PETX)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      OTC Report
      @OTCReporter

       

       


      Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PETX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of PETX and does not buy, sell, or trade any shares of PETX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/